Stock listing

Fate Therapeutics, Inc.

Selected listing: F6T · FWB · EUR · DE

Fate Therapeutics, Inc. (Frankfurt:F6T), Health Technology. Latest release Oct 5, 2026: Fate Therapeutics Reports New Employee Inducement Awards under Nasdaq…

F6T:FWBEURDEUpdated October 2, 2026
Fate Therapeutics, Inc. logo
Ticker
Frankfurt:F6T
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

About Fate Therapeutics, Inc.

Fate Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing cellular immunotherapies for cancer and immune disorders. Fate Therapeutics aims to advance its innovative therapies through research and development in the field of regenerative medicine.

Latest news from Fate Therapeutics, Inc.

All Fate Therapeutics, Inc. news →

Events

Replays

  • Fate Therapeutics, Inc. (FATE) Q1 2024 Earnings Call

    Thu, May 09, 2024 · 05:00 PM ET

    Watch
  • Fate Therapeutics, Inc. (FATE) Q4 2023 Earnings Call

    Mon, Feb 26, 2024 · 05:00 PM ET

    Watch
  • Fate Therapeutics, Inc. (FATE) Q3 2023 Earnings Call

    Wed, Nov 08, 2023 · 05:00 PM ET

    Watch

Research Fate Therapeutics, Inc.

Alternate listings